Clinical trial NCT06663735: Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
Official title: A Cross-sectional Study Describing the Current Status of Diagnosis and Treatment of Uroepithelial Cancer in Hospitals of Different Grades in Henan Province
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Uroepithelial Carcinoma
Keywords: Henan province
uroepithelial cancer
treatment
Lead sponsor: The First Affiliated Hospital of Xinxiang Medical College
Sponsor class: OTHER
First posted: 2024-10-29
Enrollment: 400
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Patients diagnosed with uroepithelial carcinoma attending multiple research center hospitals in Henan Province from January 1, 2023-December 31, 2023

Brief summary: A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province

Detailed description: Patients diagnosed with uroepithelial carcinoma attending multiple research center hospitals in Henan Province from January 1, 2023 to December 31, 2023 A questionnaire was used to collect and analyze the treatment patterns of patients with early versus advanced uroepithelial cancer in different levels of hospitals in Henan Province.

Eligibility criteria: Inclusion Criteria:

* Adults ≥18 years of age (at enrollment)
* Histologically confirmed uroepithelial carcinoma
* Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma
* Complete medical history information

Exclusion Criteria:

* Incomplete medical history and medical records

Primary outcomes:
measure: Describing the diagnosis and treatment patterns of patients with early versus advanced uroepithelial carcinoma in different grades of hospitals in Henan Province
timeFrame: up to the patients enrolled,an average of 1 year
Secondary outcomes:
measure: Comparison of differences in diagnosis and treatment patterns between patients with early-stage and advanced uroepithelial carcinoma in county hospitals and different consultation departments of the same hospital in Henan province
timeFrame: up to the patients enrolled,an average of 1 year
measure: Describing the pathology as well as genetic testing of patients with uroepithelial carcinoma in different grades of hospitals in Henan province
timeFrame: up to the patients enrolled,an average of 1 year
Other outcomes:
Locations:
city: Kaifeng
country: China
facility: Kaifeng City Center Hospital
state: Henan
city: Luoyang
country: China
facility: Luoyang Renda Hospital
state: Henan
city: Nanyang
country: China
facility: Nanyang City Center Hospital
state: Henan
city: Puyang
country: China
facility: Qingfeng County People's Hospital
state: Henan
city: Xinxiang
country: China
facility: Department of Oncology
state: Henan
city: Xinxiang
country: China
facility: Hui County People's Hospital
state: Henan
city: Xinxiang
country: China
facility: Jun County People's Hospital
state: Henan
city: Xinxiang
country: China
facility: Qi County People's Hospital
state: Henan
city: Xinxiang
country: China
facility: Xinxiang Allied Hospital
state: Henan
city: Xinxiang
country: China
facility: Xinxiang Central Hospital
state: Henan
city: Zhengzhou
country: China
facility: The First Affiliated Hospital of Zhengzhou University
state: Henan
Study officials:
References: